Lehrstuhl für Strahlentherapie

A generic curriculum development model for the biomedical physics component of the educational and training programmes of the non-physics healthcare professions (2021) Caruana CJ, Karenauskaite V, Mornstein V, Vano E, Pace E, Lammertsma AA, Maas AJ, et al. Journal article Low-grade (polymorphous) adenocarcinoma of the middle ear mimicking a jugulotympanic paraganglioma. German version (2021) Mantsopoulos K, Fietkau R, Hornung J, Agaimy A, Iro H, Taha L Journal article Identification of 15 lncRNAs Signature for Predicting Survival Benefit of Advanced Melanoma Patients Treated with Anti-PD-1 Monotherapy (2021) Zhou JG, Liang B, Liu JG, Jin SH, He SS, Frey B, Gu N, et al. Journal article Long-Term Results of the TARGIT-A Trial: More Questions than Answers (2021) Piroth MD, Strnad V, Krug D, Fastner G, Baumann R, Combs SE, Duma MN, et al. Journal article, Review article Implementation of double immune checkpoint blockade increases response rate to induction chemotherapy in head and neck cancer (2021) Semrau S, Gostian AO, Traxdorf M, Eckstein M, Rutzner S, von der Grün J, Illmer T, et al. Journal article Neoadjuvant chemoradiation combined with regional hyperthermia in locally advanced or recurrent rectal cancer (2021) Ott O, Gani C, Lindner LH, Schmidt M, Lamprecht U, Abdel-Rahman S, Hinke A, et al. Journal article The Early Landscape of Immune Cell Subsets in Metastatic NSCLC Patients Treated with Immune Checkpoint Inhibitors (2021) Zhou J, Donaubauer AJ, Frey B, Becker I, Rutzner S, Sun R, Ma H, et al. Conference contribution Exclusive endocrine therapy or partial breast irradiation for women aged ≥70years with luminal A-like early stage breast cancer (NCT04134598 – EUROPA): Proof of concept of a randomized controlled trial comparing health related quality of life by patient reported outcome measures (2021) Meattini I, Poortmans PM, Marrazzo L, Desideri I, Brain E, Hamaker M, Lambertini M, et al. Journal article Salvage-radiation therapy and regional hyperthermia for biochemically recurrent prostate cancer after radical prostatectomy (Results of the planned interim analysis) (2021) Beck M, Ghadjar P, Mehrhof F, Zips D, Paulsen F, Wegener D, Burock S, et al. Journal article Prospective development and validation of a liquid immune profile-based signature (LIPS) to predict response of patients with recurrent/metastatic cancer to immune checkpoint inhibitors (2021) Zhou J, Donaubauer AJ, Frey B, Becker I, Rutzner S, Eckstein M, Sun R, et al. Journal article, Review article